Latest Breaking News On - Oxford science enterprises - Page 1 : comparemela.com

Urinary incontinence neuromod newcomer Amber Therapeutics nets $100M

The University of Oxford spinout's series A round follows up on positive preliminary data from a first-in-human trial earlier this year.

Tiffany leAidan crawleyOxford science enterprisesUniversity of oxfordEnterprise associatesAmber therapeuticsNew enterprise associatesF prime capitalLightstone venturesIntuitive ventures

Advanced autoclave technology supports pioneering genetic research at Oxford Science Park

Nucleome Therapeutics, a leading UK biotech firm that specialises in decoding the dark genome's non-coding DNA regions to develop precision medicines for autoimmune diseases like multiple sclerosis, lupus, and rheumatoid arthritis, purchase LTE research-grade autoclave to assist with research. Click to read more.

United kingdomAnthony campbell carrPaul brackstoneOxford university bioescalatorOxford science enterprisesNucleome therapeuticsOxford universityPfizer venturesOld road campusOxford science parkSchrodinger building

SpyBiotech and University of Oxford work on EBV vaccine

SpyBiotech and University of Oxford work on EBV vaccine
oxfordmail.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from oxfordmail.co.uk Daily Mail and Mail on Sunday newspapers.

Sumi biswasSpytag spycatcherSandy douglasMark leuchtenbergerUniversity of oxfordJenner instituteOxford science enterprisesOxford based spybiotechProfessor sandy douglasUnited kingdom basedGoogle ventures

Why government regulation isn t always a clear cut issue in tech

Why government regulation isn t always a clear cut issue in tech
fortune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fortune.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesMexico cityDistrito federalUnited kingdomCity ofRepublic ofHo chi minh cityH chíinhDavid ulevitchBradley tuskAndreessen horowitzEli lillyAlexandra sternlichtJoe abramsMirus bio

SpyBiotech Adds Epstein-Barr Virus Research and Development Collaboration with The University of Oxford

Agreement to support development of a vaccine against EBV SpyBiotech, a biotechnology company with novel vaccine platform technologies that can target infectious diseases, cancer, and chronic diseases

United kingdomSumi biswasSandy douglasWilliam robinsonKaren sharmaMark leuchtenbergerSarah macleodSpytag spycatcherAdam michaelUniversity of oxfordJenner institutePowerscourt groupCenters for diseaseOxford science enterprisesChief executive officerStanford medicine